Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma

NCT06550921 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma
Oligometastasis
Ablation
Anti-PD1 Antibody
Lenvatinib

Interventions

PROCEDURE: ablation of oligometastasis

Sponsor

Sun Yat-sen University

Collaborators

[object Object]